Memoton-Life (Galantamine)

Galantamine works by reversibly inhibiting acetylcholinesterase, the enzyme that degrades acetylcholine, thereby increasing acetylcholine levels in the central nervous system. It also modulates nicotinic acetylcholine receptors, which may further support neuronal communication and cognitive processes.

The dosage of Memoton-Life is individualized. A qualified prescriber determines the appropriate starting dose and titration schedule based on the patient’s clinical condition, age, renal and hepatic function, and tolerability.

Galantamine’s pregnancy category is unknown, and there is limited data on its use during lactation. It should be avoided in pregnant or nursing women unless the potential benefit justifies the possible risk to the fetus or infant.

To request Memoton-Life, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative in the same class is donepezil, another acetylcholinesterase inhibitor. Both improve cognition in Alzheimer’s disease, but galantamine also modulates nicotinic receptors, which may offer additional benefits in attention. Safety profiles differ slightly, with galantamine more frequently causing gastrointestinal upset, while donepezil is often associated with insomnia.

Memoton-Life should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposure to direct sunlight.

Memoton-Life is taken orally, usually with food to lessen gastrointestinal irritation. Tablets should be swallowed whole with a full glass of water. The exact timing and frequency are set by the prescribing clinician.

Serious adverse events include severe liver injury, cardiac arrhythmias such as bradycardia, and seizures. Patients should be monitored for signs of jaundice, irregular heartbeat, or convulsive episodes, and the medication should be discontinued if any of these occur.

Memoton-Life is contraindicated in patients with known hypersensitivity to galantamine, severe hepatic impairment, or those with uncontrolled cardiac conduction disorders. Caution is also advised for individuals with severe asthma, COPD, or a history of seizures.